Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton. (Q35054626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

0 references

1 reference

chronic lymphocytic leukemia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Leopold Sellner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Thomas O Larsen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

B Hanna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Ohl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

T Zenz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

H Döhner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Stilgenbauer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P Lichter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Seiffert

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

27 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1289-1298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24280868%20AND%20SRC:MED&resulttype=core&format=json

From pathogenesis to treatment of chronic lymphocytic leukaemia

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

What is the best frontline therapy for patients with CLL and 17p deletion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The triterpenoid CDDO induces apoptosis in refractory CLL B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Synthesis and structure-activity relationship of griseofulvin analogues as inhibitors of centrosomal clustering in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Phenotypic taxonomy and metabolite profiling in microbial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Bio-activity and dereplication-based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The chemistry and biology of cytochalasans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Cytoskeletal changes in cell transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Cytoskeletal tumor suppressors that block oncogenic RAS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Phomacins: Three Novel Antitumor Cytochalasan Constituents Produced by a Phoma sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The antitumour activities induced by pegylated liposomal cytochalasin D in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Novel functions of vimentin in cell adhesion, migration, and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

HS1 has a central role in the trafficking and homing of leukemic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.360

Effects of chaetoglobosin J on the G-F transformation of actin

21 January 2018

1 reference

12 December 2020

Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro

1 reference

12 December 2020

Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis

1 reference

12 December 2020

Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma.

1 reference

12 December 2020

Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures

1 reference

12 December 2020

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival

1 reference

12 December 2020

Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth

1 reference

12 December 2020

Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

1 reference

12 December 2020

Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro

1 reference

12 December 2020

Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.

1 reference

12 December 2020

Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells

1 reference

12 December 2020

Chaetoglobosins, cytotoxic 10-(indol-3-yl)-[13]cytochalasans from Chaetomium spp. I. Production, isolation and some cytological effects of chaetoglobosins A-J

1 reference

12 December 2020

Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment

1 reference

12 December 2020

Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Acute toxic effects of chaetoglobosin A, a new cytochalasan compound produced by Chaetomium globosum, on mice and rats

1 reference

12 December 2020